Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study

BACKGROUND: Currently there is no effective treatment available to retard cyst growth and to prevent the progression to end-stage renal failure in patients with autosomal dominant polycystic kidney disease (ADPKD). Evidence has recently been obtained from animal experiments that activation of the ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Serra, Andreas L, Kistler, Andreas D, Poster, Diane, Struker, Marian, Wüthrich, Rudolf P, Weishaupt, Dominik, Tschirch, Frank
Formato: Texto
Lenguaje:English
Publicado: BioMed Central|1 2007
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2048941/
https://www.ncbi.nlm.nih.gov/pubmed/17868472
http://dx.doi.org/10.1186/1471-2369-8-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2048941/
https://www.ncbi.nlm.nih.gov/pubmed/17868472
http://dx.doi.org/10.1186/1471-2369-8-13

Ejemplares similares